Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 32 | $25,488,268 |
Sells | 0 | $0 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
10 May 2023 17:49 | KNTE | Kinnate Biopharma Inc | TANANBAUM JAMES B. | Director , 10% | 08 May 2023 | Purchase | 229,044 | 2.8 | 641,323 | I |
10 May 2023 17:49 | KNTE | Kinnate Biopharma Inc | TANANBAUM JAMES B. | Director , 10% | 08 May 2023 | Purchase | 1,550,956 | 2.8 | 4,342,677 | I |
10 May 2023 17:42 | KNTE | Kinnate Biopharma Inc | FORESITE CAPITAL MANAGEMENT IV, LLC | 10% | 08 May 2023 | Purchase | 229,044 | 2.8 | 641,323 | I |
10 May 2023 17:42 | KNTE | Kinnate Biopharma Inc | FORESITE CAPITAL MANAGEMENT IV, LLC | 10% | 08 May 2023 | Purchase | 1,550,956 | 2.8 | 4,342,677 | I |
08 May 2023 17:22 | KNTE | Kinnate Biopharma Inc | ORBIMED ADVISORS LLC | Director , 10% | 05 May 2023 | Purchase | 490,511 | 2.82 | 1,383,241 | I |
08 May 2023 17:22 | KNTE | Kinnate Biopharma Inc | ORBIMED ADVISORS LLC | Director , 10% | 05 May 2023 | Purchase | 490,512 | 2.82 | 1,383,244 | I |
08 May 2023 17:22 | KNTE | Kinnate Biopharma Inc | ORBIMED ADVISORS LLC | Director , 10% | 04 May 2023 | Purchase | 83,459 | 2.75 | 229,512 | I |
08 May 2023 17:22 | KNTE | Kinnate Biopharma Inc | ORBIMED ADVISORS LLC | Director , 10% | 04 May 2023 | Purchase | 312,991 | 2.75 | 860,725 | I |
08 May 2023 17:22 | KNTE | Kinnate Biopharma Inc | ORBIMED ADVISORS LLC | Director , 10% | 04 May 2023 | Purchase | 83,459 | 2.75 | 229,512 | I |
08 May 2023 17:11 | KNTE | Kinnate Biopharma Inc | GORDON CARL L | Director , 10% | 05 May 2023 | Purchase | 490,511 | 2.82 | 1,383,241 | I |
08 May 2023 17:11 | KNTE | Kinnate Biopharma Inc | GORDON CARL L | Director , 10% | 05 May 2023 | Purchase | 490,512 | 2.82 | 1,383,244 | I |
08 May 2023 17:11 | KNTE | Kinnate Biopharma Inc | GORDON CARL L | Director , 10% | 04 May 2023 | Purchase | 83,459 | 2.75 | 229,512 | I |
08 May 2023 17:11 | KNTE | Kinnate Biopharma Inc | GORDON CARL L | Director , 10% | 04 May 2023 | Purchase | 312,991 | 2.75 | 860,725 | I |
08 May 2023 17:11 | KNTE | Kinnate Biopharma Inc | GORDON CARL L | Director , 10% | 04 May 2023 | Purchase | 83,459 | 2.75 | 229,512 | I |
02 May 2023 21:38 | KNTE | Kinnate Biopharma Inc | GORDON CARL L | Director , 10% | 02 May 2023 | Purchase | 58,826 | 2.67 | 157,065 | I |
02 May 2023 21:38 | KNTE | Kinnate Biopharma Inc | GORDON CARL L | Director , 10% | 02 May 2023 | Purchase | 220,610 | 2.67 | 589,029 | I |
02 May 2023 21:38 | KNTE | Kinnate Biopharma Inc | GORDON CARL L | Director , 10% | 02 May 2023 | Purchase | 58,826 | 2.67 | 157,065 | I |
02 May 2023 21:38 | KNTE | Kinnate Biopharma Inc | GORDON CARL L | Director , 10% | 01 May 2023 | Purchase | 124,545 | 2.62 | 326,308 | I |
02 May 2023 21:38 | KNTE | Kinnate Biopharma Inc | GORDON CARL L | Director , 10% | 01 May 2023 | Purchase | 467,068 | 2.62 | 1,223,718 | I |
02 May 2023 21:38 | KNTE | Kinnate Biopharma Inc | GORDON CARL L | Director , 10% | 01 May 2023 | Purchase | 124,544 | 2.62 | 326,305 | I |
02 May 2023 21:38 | KNTE | Kinnate Biopharma Inc | GORDON CARL L | Director , 10% | 28 Apr 2023 | Purchase | 60,997 | 2.55 | 155,542 | I |
02 May 2023 21:38 | KNTE | Kinnate Biopharma Inc | GORDON CARL L | Director , 10% | 28 Apr 2023 | Purchase | 228,754 | 2.55 | 583,323 | I |
02 May 2023 21:38 | KNTE | Kinnate Biopharma Inc | GORDON CARL L | Director , 10% | 28 Apr 2023 | Purchase | 60,998 | 2.55 | 155,545 | I |
02 May 2023 21:34 | KNTE | Kinnate Biopharma Inc | ORBIMED ADVISORS LLC | Director , 10% | 02 May 2023 | Purchase | 58,826 | 2.67 | 157,065 | I |
02 May 2023 21:34 | KNTE | Kinnate Biopharma Inc | ORBIMED ADVISORS LLC | Director , 10% | 02 May 2023 | Purchase | 220,610 | 2.67 | 589,029 | I |
02 May 2023 21:34 | KNTE | Kinnate Biopharma Inc | ORBIMED ADVISORS LLC | Director , 10% | 02 May 2023 | Purchase | 58,826 | 2.67 | 157,065 | I |
02 May 2023 21:34 | KNTE | Kinnate Biopharma Inc | ORBIMED ADVISORS LLC | Director , 10% | 01 May 2023 | Purchase | 124,545 | 2.62 | 326,308 | I |
02 May 2023 21:34 | KNTE | Kinnate Biopharma Inc | ORBIMED ADVISORS LLC | Director , 10% | 01 May 2023 | Purchase | 467,068 | 2.62 | 1,223,718 | I |
02 May 2023 21:34 | KNTE | Kinnate Biopharma Inc | ORBIMED ADVISORS LLC | Director , 10% | 01 May 2023 | Purchase | 124,544 | 2.62 | 326,305 | I |
02 May 2023 21:34 | KNTE | Kinnate Biopharma Inc | ORBIMED ADVISORS LLC | Director , 10% | 28 Apr 2023 | Purchase | 60,997 | 2.55 | 155,542 | I |
02 May 2023 21:34 | KNTE | Kinnate Biopharma Inc | ORBIMED ADVISORS LLC | Director , 10% | 28 Apr 2023 | Purchase | 228,754 | 2.55 | 583,323 | I |
02 May 2023 21:34 | KNTE | Kinnate Biopharma Inc | ORBIMED ADVISORS LLC | Director , 10% | 28 Apr 2023 | Purchase | 60,998 | 2.55 | 155,545 | I |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)